ISSN: 2167-065X

Клиническая фармакология и биофармацевтика

Открытый доступ

Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.

 

Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей

Абстрактный

The Effectiveness, Safety, Adverse Drug Reactions, and Interchangeability of Biopharmaceuticals as Experienced by Public Hospital Doctors from Various Specialties: a Qualitative Study

Marconi Abreu

Although there's increasing support for biosimilar medicines by the Iraqi Ministry of Health (MOH), there's scarce info concerning whether or not physicians settle for these medicines and support movement toward commutation reference medicines with their biosimilar counterparts. The study objectives were to explore in-depth the perceptions of Iraqi physicians operating publically hospitals concerning the distinction in effectiveness and safety between biosimilar medicines and their reference biological counterparts, assess physicians' barriers to prescribing biosimilar medicines, assess the adherence of physicians to the new pharmacovigilance rules on news biopharmaceutical adverse drug reactions (ADRs) and establish any barriers facing physicians to news biopharmaceutical ADRs.his qualitative study enclosed face-to-face and virtual semi-structured interviews involving physicians from completely different disciplines UN agency had expertise with biological or biosimilar medicines.